Hunt Hazel bought CORT
February 27, 2026 · Form 4 insider transaction
Hunt Hazel bought 140,000 shares of Corcept Therapeutics Incorporated at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
140,000
Price
$0.00
Total value
N/A
InsiderHunt Hazel
RoleOfficer
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateFebruary 27, 2026
Filing dateMarch 3, 2026
Shares owned after140,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Exercise ratably in equal installments on each monthly anniversary of February 27, 2026 over a four-year period subject to the Reporting Person's continued service through each vesting date.